Fludarabine + Cyclophosphamide

DRUG3 trials

Sponsors

Corregene Biotechnology Co., Ltd, HRYZ Biotech Co.

Conditions

Anal CancerAnal CarcinomaCarcinoma of PenisCarcinoma of VaginaCarcinoma of VulvaCervical CancerHead and Neck CancersHead and Neck Squamous Cell Carcinoma

Phase 1

CRTE7A2-01 TCR-T Cell for HPV-16 Positive Advanced Cervical, Anal, or Head and Neck Cancers

Corregene Biotechnology Co., LtdAnal Cancer, Cervical Cancer, Head and Neck Cancers

Start: 2022-07-17End: 2024-12-31Target: 12Updated: 2022-06-28

HRYZ-T101 TCR-T Cell for HPV-18 Positive Advanced Solid Tumor

HRYZ Biotech Co.Anal Carcinoma, Carcinoma of Penis, Carcinoma of Vulva +4

Start: 2023-03-21End: 2025-09-30Target: 17Updated: 2024-02-02

HRYZ-T101 Injection for HPV18 Positive Solid Tumor

RecruitingNCT05952947

HRYZ Biotech Co.Anal Cancer, Carcinoma of Penis, Carcinoma of Vagina +3

Start: 2023-11-01End: 2028-02-29Target: 32Updated: 2024-02-02

Related Papers

Abstract 26: An HLA-class II restricted HPV18 E7 specific TCR cloned from a long-term surviving cervical cancer patient

Cancer Research2024-03-22